Sophie Boisbouvier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sophie Boisbouvier has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
A. De Oliveira
Departement de Radiotherapie, Institut Curie, Paris, France
2 shared publicationsS. Corbin
Département de radiothérapie, institut Gustave-Roussy, Villejuif, France
2 shared publicationsTracy Underwood
Research Department, Leo Cancer Care Ltd, Crawley, United Kingdom
2 shared publicationsA. Béasse
1 shared publication- A. Béasse
Fondation Cognacq-Jay, hôpital Forcilles, département de radiothérapie, Lieu-dit Forcilles, 77150 Férolles-Attilly, France
1 shared publication A. Hasbini
Département de radiothérapie, clinique Pasteur, Brest, France
1 shared publication
Latest Publications
- Open Access
- 8 May 2026
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 38, 100409
Upright versus supine positioning for breast and lung radiotherapy: a pilot study on patient comfort, experience and lung function
- 8 May 2026
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 38, 100409
Open AccessUpright versus supine positioning for breast and lung radiotherapy: a pilot study on patient comfort, experience and lung function
- Open Access
- 2 May 2026
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 38, 100410
Will upright radiotherapy become a new standard? STAND: Perspectives and acceptability from the global radiotherapy community
- 2 May 2026
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 38, 100410
Open AccessWill upright radiotherapy become a new standard? STAND: Perspectives and acceptability from the global radiotherapy community
- 6 August 2025
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 29 (5-6) , 104686
Radiation therapist, a key player in radiotherapy research
- 6 August 2025
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 29 (5-6) , 104686
Radiation therapist, a key player in radiotherapy research
- Open Access
- 29 April 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 34
Radiography students wishing to work in the field of radiation therapy: A French experience
- 29 April 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 34
Open AccessRadiography students wishing to work in the field of radiation therapy: A French experience
- 25 September 2024
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 28 (6-7) , 560-564
Committee of the new positions of the Société française de radiothérapie oncologique: Toward an advanced practice master in radiotherapy
- 25 September 2024
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 28 (6-7) , 560-564
Committee of the new positions of the Société française de radiothérapie oncologique: Toward an advanced practice master in radiotherapy
- Open Access
- 29 July 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (8) , 802
Radiosurgery in Grade II and III Meningiomas: A Systematic Review and Meta-Analysis
Background: Meningiomas are the most prevalent benign intracranial tumors. When they are of the invasive subtypes, i.e., grades II and III, they can recur rapidly and present a real challenge for physicians. This study is focused on the use of stereotactic radiosurgery to manage high-grade meningiomas. Method: Medline via PubMed was searched from inception to December 2022 to retrieve studies on stereotactic radiation therapy for patients with grade II-III meningiomas. This study was conducted under PRISMA guidelines. Result: A total of 29 articles involving 1446 patients with grade II-III meningiomas treated with stereotactic radiation therapy were included in the present study. Of these studies, 11 were conducted exclusively on patients with atypical meningiomas (grade II), 1 targeted anaplastic meningiomas (grade III), and 17 articles were carried out on both grade II and III meningiomas. The pooled 1, 2, 3, 5, and 10-year overall survival (OS) of grade II meningiomas was 0.96 [p < 0.01], 0.89 [p = 0.01], 0.90 [p = 0.09], 0.81 [p < 0.01], and 0.66 [p = 0.55], respectively. The pooled 2, 5, and 10-year OS of grade III meningiomas was 0.64 [p = 0.01], 0.41 [p = 0.01], and 0.19 [p < 0.01], respectively. Conclusions: Although long-term prospective studies are still required, the outcomes of stereotactic radiation therapy appear promising regarding overall outcome and progression-free survival.
- 29 July 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (8) , 802
Open AccessRadiosurgery in Grade II and III Meningiomas: A Systematic Review and Meta-Analysis
Background: Meningiomas are the most prevalent benign intracranial tumors. When they are of the invasive subtypes, i.e., grades II and III, they can recur rapidly and present a real challenge for physicians. This study is focused on the use of stereotactic radiosurgery to manage high-grade meningiomas. Method: Medline via PubMed was searched from inception to December 2022 to retrieve studies on stereotactic radiation therapy for patients with grade II-III meningiomas. This study was conducted under PRISMA guidelines. Result: A total of 29 articles involving 1446 patients with grade II-III meningiomas treated with stereotactic radiation therapy were included in the present study. Of these studies, 11 were conducted exclusively on patients with atypical meningiomas (grade II), 1 targeted anaplastic meningiomas (grade III), and 17 articles were carried out on both grade II and III meningiomas. The pooled 1, 2, 3, 5, and 10-year overall survival (OS) of grade II meningiomas was 0.96 [p < 0.01], 0.89 [p = 0.01], 0.90 [p = 0.09], 0.81 [p < 0.01], and 0.66 [p = 0.55], respectively. The pooled 2, 5, and 10-year OS of grade III meningiomas was 0.64 [p = 0.01], 0.41 [p = 0.01], and 0.19 [p < 0.01], respectively. Conclusions: Although long-term prospective studies are still required, the outcomes of stereotactic radiation therapy appear promising regarding overall outcome and progression-free survival.
- 12 June 2024
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 28 (3) , 229-235
A prospective observational study evaluating two patient immobilisation methods in lung stereotactic radiotherapy
- 12 June 2024
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 28 (3) , 229-235
A prospective observational study evaluating two patient immobilisation methods in lung stereotactic radiotherapy
- 25 October 2023
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 27 (8) , 712-717
Enquête SFRO–SNRO–AFPPE sur l’évolution du métier de manipulateur exerçant en radiothérapie en France
- 25 October 2023
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 27 (8) , 712-717
Enquête SFRO–SNRO–AFPPE sur l’évolution du métier de manipulateur exerçant en radiothérapie en France
- Open Access
- 22 September 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1250678
Upright patient positioning for gantry-free breast radiotherapy: feasibility tests using a robotic chair and specialised bras
For external beam radiotherapy using photons or particles, upright patient positioning on a rotating, robotic chair (a gantry-less system) could offer substantial cost savings. In this study, we considered the feasibility of upright breast radiotherapy using a robotic radiotherapy chair, for (i) a cohort of 9 patients who received conventional supine radiotherapy using photons for a diagnosis of primary breast cancer, plus (ii) 7 healthy volunteers, selected to have relatively large bra cup sizes. We studied: overall body positioning, arm positioning, beam access, breast reproducibility, and comfort. Amongst the healthy volunteer cohort, the impact of specialised radiotherapy bras upon inframammary skinfolds (ISF) was also determined, for upright treatment positions. In conclusion, upright body positioning for breast radiotherapy appears to be comfortable and feasible. Of the 9 patients who received conventional, supine radiotherapy (mean age 63.5 years, maximum age 90 years), 7 reported that they preferred upright positioning. Radiotherapy bras were effective in reducing/eliminating ISF for upright body positions, including for very large breasted volunteers. For upright proton radiotherapy to the breast, beam access should be straightforward, even for arms-down treatments, as en-face field directions are typically used. For photon radiotherapy, additional research is now required to investigate beam paths and whether, for certain patients, additional immobilisation will be required to keep the contralateral breast free from exposure. Future research should also investigate arm supports custom-designed for upright radiotherapy.
- 22 September 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1250678
Open AccessUpright patient positioning for gantry-free breast radiotherapy: feasibility tests using a robotic chair and specialised bras
For external beam radiotherapy using photons or particles, upright patient positioning on a rotating, robotic chair (a gantry-less system) could offer substantial cost savings. In this study, we considered the feasibility of upright breast radiotherapy using a robotic radiotherapy chair, for (i) a cohort of 9 patients who received conventional supine radiotherapy using photons for a diagnosis of primary breast cancer, plus (ii) 7 healthy volunteers, selected to have relatively large bra cup sizes. We studied: overall body positioning, arm positioning, beam access, breast reproducibility, and comfort. Amongst the healthy volunteer cohort, the impact of specialised radiotherapy bras upon inframammary skinfolds (ISF) was also determined, for upright treatment positions. In conclusion, upright body positioning for breast radiotherapy appears to be comfortable and feasible. Of the 9 patients who received conventional, supine radiotherapy (mean age 63.5 years, maximum age 90 years), 7 reported that they preferred upright positioning. Radiotherapy bras were effective in reducing/eliminating ISF for upright body positions, including for very large breasted volunteers. For upright proton radiotherapy to the breast, beam access should be straightforward, even for arms-down treatments, as en-face field directions are typically used. For photon radiotherapy, additional research is now required to investigate beam paths and whether, for certain patients, additional immobilisation will be required to keep the contralateral breast free from exposure. Future research should also investigate arm supports custom-designed for upright radiotherapy.
- 21 July 2023
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 27 (6-7) , 583-587
Les prémices de la pratique avancée pour le manipulateur en radiothérapie
- 21 July 2023
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 27 (6-7) , 583-587
Les prémices de la pratique avancée pour le manipulateur en radiothérapie